Inventiva has been granted a patent for compounds of formula (I), with specific definitions for R1, R2, R3, R4, R5. Claim 1 specifically covers a compound of formula (I). GlobalData’s report on Inventiva gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Inventiva, Human telomerase RT biomarker was a key innovation area identified from patents. Inventiva's grant share as of May 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Chemical compounds with specific formula
A recently granted patent (Publication Number: US11999758B2) discloses a compound of formula (I) and its pharmaceutically acceptable salts, with specific variations in the structure outlined in the claims. The compound is designed for the treatment of cancers where YAP is localized in the nucleus of tumor cells, including lung, thyroid, ovarian, colorectal, prostate, pancreas, esophagus, liver, breast, skin cancer, and malignant mesothelioma. The patent also covers pharmaceutical compositions containing the compound and methods for administering it to patients in need of treatment.
The patent further details specific compounds within the formula (I) category, along with their variations and pharmaceutically acceptable salts, for the treatment of cancers with YAP localization in tumor cell nuclei. These compounds are intended for use in pharmaceutical compositions with suitable excipients. The methods outlined in the patent provide a targeted approach to treating various cancers, emphasizing the importance of YAP localization in tumor cells. The disclosed compounds offer potential therapeutic benefits for patients with different types of cancer, including malignant mesothelioma, by specifically targeting the underlying molecular mechanisms associated with YAP localization.
To know more about GlobalData’s detailed insights on Inventiva, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
